Literature DB >> 27412667

[Glucocorticoids].

E Gromnica-Ihle1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27412667     DOI： 10.1007/s00393-016-0115-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  27 in total

1.  SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

Authors:  J R DEANDRADE; J N MCCORMICK; A G HILL
Journal:  Ann Rheum Dis       Date:  1964-03       Impact factor: 19.103

2.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

3.  History of the development of corticosteroid therapy.

Authors:  T G Benedek
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

4.  Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.

Authors:  Marije F Bakker; Johannes W G Jacobs; Paco M J Welsing; Suzanne M M Verstappen; Janneke Tekstra; Evelien Ton; Monique A W Geurts; Jacobine H van der Werf; Grietje A van Albada-Kuipers; Zalima N Jahangier-de Veen; Maaike J van der Veen; Catharina M Verhoef; Floris P J G Lafeber; Johannes W J Bijlsma
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

5.  Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Amalia A van Everdingen; Johannes W G Jacobs; Dirk R Siewertsz Van Reesema; Johannes W J Bijlsma
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

Review 6.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

Review 7.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

8.  Low dose prednisone therapy in rheumatoid arthritis: a double blind study.

Authors:  E D Harris; R D Emkey; J E Nichols; A Newberg
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

9.  Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study.

Authors:  Carlomaurizio Montecucco; Monica Todoerti; Garifallia Sakellariou; Carlo Alberto Scirè; Roberto Caporali
Journal:  Arthritis Res Ther       Date:  2012-05-14       Impact factor: 5.156

10.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maya Buch; Gerd Burmester; Maxime Dougados; Paul Emery; Cécile Gaujoux-Viala; Laure Gossec; Jackie Nam; Sofia Ramiro; Kevin Winthrop; Maarten de Wit; Daniel Aletaha; Neil Betteridge; Johannes W J Bijlsma; Maarten Boers; Frank Buttgereit; Bernard Combe; Maurizio Cutolo; Nemanja Damjanov; Johanna M W Hazes; Marios Kouloumas; Tore K Kvien; Xavier Mariette; Karel Pavelka; Piet L C M van Riel; Andrea Rubbert-Roth; Marieke Scholte-Voshaar; David L Scott; Tuulikki Sokka-Isler; John B Wong; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-10-25       Impact factor: 19.103
View more
  2 in total

1.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

Review 2.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.